Pseudoangiomatous Stromal Hyperplasia: Diagnosis, Treatment andFollow-Up; Description of a Case-Series

  title={Pseudoangiomatous Stromal Hyperplasia: Diagnosis, Treatment andFollow-Up; Description of a Case-Series},
  author={Willem Donk and Rob J Oostenbroek and Remmert K. Storm and Pieter J. Westenend and Peter W. Plaisier},
  journal={The Open Breast Cancer Journal},
Pseudoangiomatous stromal hyperplasia (PASH) is a benign lesion of the breast. Mammography and ultrasonography usually reveal a well circumscribed lesion with benign characteristics. In this report a series of 36 patients is described in terms of imaging, histopathologic findings, therapy and followup. Also an overview of the literature is provided. No standard excision is necessary for PASH proven by core needle biopsy. However, it should be noted that PASH may be an incidental finding not… 

Tables from this paper

A Rare Case Presenting with Breast Mass Pseudoangiomatous Stromal Hyperplasia

A case of a 45-year-old woman who presented with right-sided pain and mass complaints and was diagnosed as PSAH by surgical excision is presented.

Breast Imaging Chameleon: Pseudoangiomatous Stromal Hyperplasia Presenting as Breast Malignancy

A lactating female presented with gross left breast enlargement due to a huge firm mass with skin thickening and palpable left axillary lymph nodes, and the histopathology revealed PASH of the breast.

Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.

A Case Report: Pseudoangiomatous Stromal Hyperplasia Tumor Presenting as a Palpable Mass

A core biopsy of a woman with a palpable lump on her left breast revealed a pseudoangiomatous stromal hyperplasia of the breast, a heterogeneous mass with smooth and lobulated borders.



Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia.

PASH is a common entity that presents with benign imaging features without evidence of subsequent malignant potential, and in the absence of suspicious features a diagnosis at core biopsy is considered sufficient, and surgical excision has been obviated.

Fine‐needle aspiration cytology of pseudoangiomatous stromal hyperplasia of the breast

Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon lesion usually found in premenopausal women and may pose diagnostic challenge to surgical pathologists.

Tamoxifen in the Management of Pseudoangiomatous Stromal Hyperplasia

An impressive response to tamoxifen is reported in a patient with PASH presenting with breast enlargement, pain, and breast masses, similar to a fibroadenoma in clinical and imaging features.

Diagnosis of Pseudoangiomatous Stromal Hyperplasia of the Breast: Ultrasonography Findings and Different Biopsy Methods

Purpose Pseudoangiomatous stromal hyperplasia (PASH) of the breast is a rare, benign condition that can be mistaken as a fibroadenoma on an ultrasound examination or as a low-grade angiosarcoma on a

Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances.

Pseudoangiomatous stromal hyperplasia should be included in the differential diagnosis of a circumscribed or partially circumscribed mass, especially in the premenopausal population, because these masses often grow over time and can recur locally.

Tumoral Pseudoangiomatous Stromal Hyperplasia of the Breast

A review of the literature revealed that 90 per cent of patients with PASH had some malignant imaging characteristics and 95 per cent had a mass on mammography, and the imaging characteristics of PASH exhibited marked variability.

Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases

All pseudoangiomatous stromal hyperplasia tumors diagnosed by core needle biopsy but not subsequently excised remained clinically and radiologically stable; therefore, offering the option of close clinical surveillance instead of surgery in patients with pseudoangio-stromalhyperplasia tumor diagnosis is offered.

Pseudoangiomatous hyperplasia of mammary stroma.

Pseudoangiomatous Stromal Hyperplasia and Breast Cancer Risk

Lower levels of breast cancer risk for the PASH group persisted in analyses stratified by age, family history, epithelial proliferation, and involution, despite clinical concern generated by palpable density often associated with PASH.

Immunocytochemical Analysis of Estrogen and Progesterone Receptors in Benign Stromal Lesions of the Breast: Evidence for Hormonal Etiology in Pseudoangiomatous Hyperplasia of Mammary Stroma

The contention that pseudoangiomatous hyperplasia represents a localized form of stromal overgrowth with a hormonal (primarily progestagenic) etiology is supported and the heterogeneity of socalled mammary hamartomas is highlighted by demonstrating dramatically different progesterone receptor immunoreactivity patterns in myoid lesions as compared with other hamartoma variants.